Prognosis
EU, Gilead Reach Deal on Supply of Antiviral Drug Remdesivir
- 63 million-euro contract for treatment of Covid-19 patients
- Deal also ensures antiviral treatment’s supplies for the U.K.
One vial of Remdesivir.
Photographer: Ulrich Perrey/AFP via Getty Images
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The European Union reached an agreement with Gilead Sciences Inc. for supplies of the company’s antiviral drug remdesivir to combat the coronavirus.